Tiotropium Bromide
4 NDCs across 2 manufacturers|1 Generic,3 Brand
Tiotropium Bromide is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 30, 2004, and the first generic was approved Jun 20, 2023. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1.5 billion on Tiotropium Bromide across 2.1 million claims for 551,000 beneficiaries.
Tiotropium Bromide is available as 4 NDCs from 2 manufacturers (1 generic, 3 brand), with NADAC prices from $10.60 to $11.81 per EA — a 11% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
1G / 3B
Manufacturers
2
competing in market
Price Spread
$10.60 – $11.81
per EA
7d Activity
avg +0.1% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Boehringer Ingelheim Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing TIOTROPIUM BROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TIOTROPIUM 18 MCG CAP-INHALER | $11.8109 per EA | +0.84% |
SPIRIVA HANDIHALER 18 MCG CAP | $11.6790 per EA | -0.48% |
SPIRIVA HANDIHALER 18 MCG CAP | $10.6199 per EA | +0.04% |
SPIRIVA HANDIHALER 18 MCG CAP | $10.6048 per EA | -0.12% |
Frequently Asked Questions
What is Tiotropium Bromide used to treat?
Tiotropium Bromide is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.
When did Tiotropium Bromide become available as a generic?
FDA approved the first generic Tiotropium Bromide (ANDA) on Jun 20, 2023. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tiotropium Bromide?
In 2024, Medicare Part D spent $1.5 billion on Tiotropium Bromide across 2.1 million claims for 551,000 beneficiaries.
How many Tiotropium Bromide products are on the market?
The Tiotropium Bromide drug market contains 4 NDCs from 2 manufacturers — 1 generic and 3 brand products.
What is the price range for Tiotropium Bromide?
NADAC reference prices for Tiotropium Bromide range from $10.6048 to $11.8109 per EA — a 11% difference between cheapest and most expensive.
Is generic Tiotropium Bromide cheaper than brand?
The average generic NADAC for Tiotropium Bromide is $11.8109 per EA, versus $10.9679 for brand-labeled products — brand is currently about 7% cheaper on average.
Which manufacturers make Tiotropium Bromide?
2 manufacturers list Tiotropium Bromide in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (3), Lupin Pharmaceuticals Inc. (1).
How has the price of Tiotropium Bromide changed recently?
Over the past 7 days, 2 Tiotropium Bromide NDCs rose and 2 fell, with a market-wide average change of +0.1%.